Dearomative cycloaddition: current trends in polycyclic indoline synthesis
Organic & Biomolecular Chemistry · 2026 · 24 (15) · 3119-3179
DOI: 10.1039/d5ob01885d ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Organic & Biomolecular Chemistry, 2026. Verfasst von Aditi Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow, 226007, Uttar Pradesh, India. chem.shashi@gmail.com. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Department of Higher Education.
Abstract (Originalsprache)
The review emphasizes the significance of dearomative cycloaddition reactions for constructing polycyclic indoline frameworks, covering recent advancements, mechanistic insights, and future research directions (2019–2025).
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow, 226007, Uttar Pradesh, India. chem.shashi@gmail.com.
- School of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala-147004, Punjab, India. vikas.tyagi@thapar.edu.
Förderung
- Council of Scientific and Industrial Research, India
- Department of Higher Education
Zitieren
APA
Singh, A., Kalhans, P., Tyagi, V., & Pandey, S. (2026). Dearomative cycloaddition: current trends in polycyclic indoline synthesis. Organic & Biomolecular Chemistry, 24(15), 3119-3179. https://doi.org/10.1039/d5ob01885d
Vancouver
Singh A, Kalhans P, Tyagi V, Pandey S. Dearomative cycloaddition: current trends in polycyclic indoline synthesis. Organic & Biomolecular Chemistry. 2026;24(15):3119-3179. doi:10.1039/d5ob01885d
BibTeX
@article{Singh2026,
author = {Singh, Aditi and Kalhans, Prashasti and Tyagi, Vikas and Pandey, Shashi},
title = {Dearomative cycloaddition: current trends in polycyclic indoline synthesis},
journal = {Organic & Biomolecular Chemistry},
year = {2026},
volume = {24},
number = {15},
pages = {3119--3179},
doi = {10.1039/d5ob01885d}
}
EUVIMED